|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBSCO_ocn829233164 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130307s2012 nyua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d YDXCP
|d EBLCP
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d AGLDB
|d OCLCF
|d OCLCQ
|d VTS
|d AU@
|d STF
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781612091792
|q (electronic bk.)
|
| 020 |
|
|
|a 1612091792
|q (electronic bk.)
|
| 020 |
|
|
|z 9781619426740
|
| 020 |
|
|
|z 1619426749
|
| 029 |
1 |
|
|a DEBBG
|b BV041049628
|
| 029 |
1 |
|
|a DEBBG
|b BV043774872
|
| 029 |
1 |
|
|a DEBSZ
|b 449539628
|
| 029 |
1 |
|
|a DEBSZ
|b 472772732
|
| 035 |
|
|
|a (OCoLC)829233164
|
| 050 |
|
4 |
|a QR201.H46
|
| 072 |
|
7 |
|a MED
|x 114000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.3623
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Hepatitis C virus :
|b epidemiology, pathogenesis & treatment /
|c edited by Alvaro Perez Gonzales, Angel Alonso Verracruz.
|
| 260 |
|
|
|a Hauppauge, N.Y. :
|b Nova Science,
|c 2012.
|
| 300 |
|
|
|a 1 online resource (xi, 132 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a HEPATITIS C VIRUS:EPIDEMIOLOGY, PATHOGENESISAND TREATMENT; VIROLOGY RESEARCH PROGRESS; HEPATOLOGY RESEARCHAND CLINICAL DEVELOPMENTS; HEPATITIS C VIRUS:EPIDEMIOLOGY, PATHOGENESISAND TREATMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; CHAPTER 1. Management of Hepatitis C VirusInfection in the Genomic Era; ABSTRACT; ABBREVIATIONS; INTRODUCTION; APPROACHES TO INVESTIGATE HOST GENETICVARIATIONS; HOST GENETIC VARIATIONS AND HCV INFECTIONWITH CANDIDATE GENE APPROACH; GENOME-WIDE ASSOCIATION STUDIES IN HCVINFECTION.
|
| 505 |
8 |
|
|a IMPACT OF GWAS FINDINGS ON INTERFERONBASEDTHERAPY OF CHCIMPACT OF GWAS FINDINGSON NOVEL ANTI-HCV AGENTS; CONCLUSIONS; DISCLOSURE OF CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 2. Hepatic and Blood Dendritic CellSubsets in Patients with ChronicHepatitis C Virus Infection; ABSTRACT; HEPATITIS C VIRUS; DENDRITIC CELL SUBSETS; DENDRITIC CELLS IN HCV-INFECTED BLOOD; DENDRITIC CELLS IN THE LIVER; FUTURE DIRECTION ; CONCLUSION; BIBLIOGRAPHY; CHAPTER 3. Bone Metabolism Disordersin Chronic Hepatitis C VirusInfection; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION.
|
| 505 |
8 |
|
|a 2. EPIDEMIOLOGY. CHRONIC LIVER DISEASEAND PREVALENCE OF HEPATIC OSTEODYSTROPHY. PREVALENCE OF HEPATIC OSTEODYSTROPHYIN CHRONIC HEPATITIS C3. PATHOPHYSIOLOGY: PATHOGENIC MECHANISMSINVOLVED IN BONE MASS LOSSIN CHRONIC HEPATITIS C INFECTION; Calcium and Vitamin D Disorders; Insulin-like Growth Factor 1 Deficiency (IGF-1) Deficiency; Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL)and Osteoprotegerin (OPG); Hypogonadism; Hyperbilirubinemia; Genetic Factors; Lifestyle Factors; DIAGNOSIS OF HEPATIC OSTEODYSTROPHYIN CHRONIC HEPATITIS C.
|
| 505 |
8 |
|
|a THERAPEUTIC MANAGEMENT OF HEPATICOSTEODYSTROPHY IN CHRONIC HEPATITIS CGeneral Measures. Vitamin D and Calcium Supplementation; Anti-osteoporotic Drugs in the Treatment of HepaticOsteodystrophy; Antiviral Drugs and their Effect on BMD; Orthotopic Liver Transplantation and Bone Mineral Density inChronic Hepatitis C; CONCLUSIONS; REFERENCES; CHAPTER 4. SOCS1 Involvement in LiverDamage during Hepatitis C VirusInfection; ABSTRACT; INTRODUCTION; THE SOCS FAMILY; STRUCTURE; SOCS1; THE BIOLOGICAL FUNCTION OF SOCS1; SOCS1 EXPRESSION DURING HEPATITIS CVIRUS INFECTION; ROLE OF SOCS1 IN LIVER STEATOSIS.
|
| 505 |
8 |
|
|a INACTIVATION OF SOCS1AND INDUCTION OF FIBROSISROLE OF SOCS1IN THE CONTROL OF CARCINOGENESIS; SOCS1 SILENCING AND HCC; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 5. Asymptomatic Low-LevelHepatitis C Virus Persistence; ABSTRACT; INTRODUCTION; HCV INFECTION OF THE LYMPHATIC SYSTEM; ASYMPTOMATIC LOW-LEVEL HCV PERSISTENCE; Occult HCV Infection Following Clinical Resolutionof Hepatitis C; Occult HCV Infection with Undefined Etiology; OCCULT HCV INFECTION IS NOT UNIVERSALLYDETECTED: BRIDGING THE GAPS; CLINICAL RELEVANCE OF OCCULT HCVINFECTION: TO BE OR NOT TO BE?; CONCLUSION; REFERENCES.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Hepatitis C virus.
|
| 650 |
|
0 |
|a Hepatitis C virus
|x Treatment.
|
| 650 |
|
0 |
|a Hepatitis C virus
|x Epidemiology.
|
| 650 |
|
0 |
|a Hepatitis C virus
|x Pathogenesis.
|
| 650 |
|
2 |
|a Hepacivirus
|
| 650 |
|
6 |
|a Virus de l'hépatite C.
|
| 650 |
|
6 |
|a Virus de l'hépatite C
|x Traitement.
|
| 650 |
|
6 |
|a Virus de l'hépatite C
|x Épidémiologie.
|
| 650 |
|
6 |
|a Virus de l'hépatite C
|x Pathogenèse.
|
| 650 |
|
7 |
|a MEDICAL
|x Hepatology.
|2 bisacsh
|
| 650 |
|
7 |
|a Hepatitis C virus.
|2 fast
|0 (OCoLC)fst00955217
|
| 700 |
1 |
|
|a Gonzales, Alvaro Perez.
|
| 700 |
1 |
|
|a Verracruz, Angel Alonso.
|
| 776 |
0 |
8 |
|i Print version:
|t Hepatitis C virus.
|d Hauppauge, N.Y. : Nova Science, 2012
|z 9781619426740
|w (OCoLC)800860795
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=539996
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3018946
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10662752
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 539996
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 7422401
|
| 994 |
|
|
|a 92
|b IZTAP
|
